Advertisement

Community Mental Health Journal

, Volume 54, Issue 5, pp 571–577 | Cite as

Oxford House Residents’ Attitudes Toward Medication Assisted Treatment Use in Fellow Residents

  • John M. Majer
  • Christopher Beasley
  • Emily Stecker
  • Ted J. Bobak
  • Joshua Norris
  • Hai Minh Nguyen
  • Maisie Ogata
  • Jordana Siegel
  • Brandon Isler
  • Elzbieta Wiedbusch
  • Leonard A. Jason
Brief Report

Abstract

Methadone and buprenorphine/naloxone are medication assisted treatment (MAT) options for treating opioid use disorder, yet attitudes regarding their use within abstinence-based recovery homes have not been assessed. The present investigation examined attitudes regarding MAT utilization among residents living in Oxford Houses. This cross-sectional investigation compared residents (n = 87) receiving MAT whose recent drug use involved opioids, and two groups not receiving MATs; those who had used opioids and those who had used substances other than opioids. The vast majority of residents were not receiving MAT, yet 32% reported MAT histories. Negative attitudes regarding MAT were observed among residents who were not receiving MAT. Those presently receiving MAT reported mixed attitudes regarding the use of methadone and buprenorphine/naloxone, and two of these residents reported they had never been prescribed MAT. Findings suggest that abstinence-based recovery homes such as Oxford Houses may not be optimal resources for persons receiving MATs.

Keywords

Medication assisted treatment Abstinence-based recovery homes Oxford House Methadone Buprenorphine/naloxone Suboxone 

Notes

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Bart, G. (2012). Maintenance medication for opiate addiction: the foundation of recovery. Journal of Addictive Diseases, 31(3), 207–225.  https://doi.org/10.1080/10550887.2012.694598.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Bretteville-Jensen, A. L., Lillehagen, M., Gjersing, L., & Andreas, J. B. (2015). Illicit use of opioid substitution drugs: prevalence, user characteristics, and the association with non-fatal overdoses. Drug and Alcohol Dependence, 147, 89–96.  https://doi.org/10.1016/j.drugalcdep.2014.12.002.CrossRefPubMedGoogle Scholar
  3. Center for Behavioral Health Statistics and Quality. (2016). Key substance use and mental health indicators in the United States: Results from the 2015 National Survey on Drug Use and Health (HHS Publication No. SMA 16-4984, NSDUH Series H-51). Retrieved June 26, 2017, from http://www.samhsa.gov/data/.
  4. Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014). The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry, 71, 821–826.  https://doi.org/10.1001/jamapsychiatry.2014.366.CrossRefPubMedGoogle Scholar
  5. Dart, R. C., Surratt, H. L., Cicero, T. J., Parrino, M. W., Severtson, S. G., Bucher-Bartelson, B., & Green, J. L. (2015). Trends in opioid analgesic abuse and mortality in the United States. The New England Journal of Medicine, 372, 241–248.  https://doi.org/10.1056/NEJMsa1406143.CrossRefPubMedGoogle Scholar
  6. Dole, V. P. (1988). Implications of methadone maintenance for theories of narcotic addiction. Journal of the American Medical Association, 260, 3025–3029.CrossRefPubMedGoogle Scholar
  7. Dole, V. P., & Nyswander, M. E. (1967). Heroin addiction—A metabolic disease. Archives of Internal Medicine, 120, 19–24.CrossRefPubMedGoogle Scholar
  8. Gowing, L., Ali, R., & White, J. M. (2004). Buprenorphine for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews Issue 4. Art. No.: CD002025.pub2.  https://doi.org/10.1002/14651858.CD002025.pub4.
  9. Hasan, M. K., & Hasan, O. K. (2011). Opiate addiction and prescription drug abuse: A pragmatic approach. Journal of the Islamic Medical Association of North America, 43, 23–26.  https://doi.org/10.5915/43-1-6509.CrossRefGoogle Scholar
  10. Hill, D. R., Conroy, S., Afzal, A., Lang, D., Steele, S., & Campbell, D. (2015). A comparison of methadone and buprenorphine-naloxone as opioid substitution therapy: The patient perspective in NHS Lanarkshire. Journal of Substance Use, 20, 168–177.  https://doi.org/10.3109/14659891.2014.894589.CrossRefGoogle Scholar
  11. Jason, L. A., Davis, M. I., Ferrari, J., & Anderson, E. (2007). The need for substance Abuse after-care: Longitudinal analysis of Oxford House. Addictive Behaviors, 32, 803–818.  https://doi.org/10.1016/j.addbeh.2006.06.014.CrossRefPubMedGoogle Scholar
  12. Jason, L. A., Olson, B. D., & Foli, K. (2008). Rescued lives: The Oxford House approach to substance abuse. New York: Routledge.Google Scholar
  13. Johnson, B., & Richert, T. (2015a). Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: Prevalence estimates. International Journal of Drug Policy, 26, 183–190.  https://doi.org/10.1016/j.drugpo.2014.10.003.CrossRefPubMedGoogle Scholar
  14. Johnson, B., & Richert, T. (2015b). Diversion of methadone and buprenorphine from opioid substitution treatment: The importance of patients’ attitudes and norms. Journal of Substance Abuse Treatment, 54, 50–55.  https://doi.org/10.1016/j.jsat.2015.01.013.CrossRefPubMedGoogle Scholar
  15. Kiepek, N., Hancock, L., Toppozini, D., Cromarty, H., Morgan, A., & Kelly, L. (2012). Facilitating medical withdrawal from opiates in rural Ontario. Rural and Remote Health, 12, 2193–2193.PubMedGoogle Scholar
  16. Majer, J. M., Jason, L. A., Ferrari, J., & Miller, S. A. (2011). 12-step involvement among a U.S. national sample of Oxford House residents. Journal of Substance Abuse Treatment, 41, 37–44.  https://doi.org/10.1016/j.jsat.2011.01.010.CrossRefPubMedPubMedCentralGoogle Scholar
  17. Majer, J. M., Jason, L. A., Ferrari, J., Venable, L. B., & Olson, B. D. (2002). Social support and self-efficacy for abstinence: Is peer identification an issue? Journal of Substance Abuse Treatment, 23, 209–215.CrossRefPubMedGoogle Scholar
  18. Mercadante, S., Sapio, M., Serretta, R., & Caligara, M. (1996). Patient-controlled analgesia with oral methadone in cancer pain: Preliminary report. Annals of Oncology, 7, 613–617.CrossRefPubMedGoogle Scholar
  19. Narcotics Anonymous. (2008). Narcotics Anonymous: Basic text (6th edn.). Van Nuys: World Service Office.Google Scholar
  20. Narcotics Anonymous. (2016). Narcotics Anonymous and persons receiving medication-assisted treatment. Retrieved June 26, 2017, from https://www.na.org/admin/include/spaw2/uploads/pdf/pr/2306_NA_PRMAT_1021.pdf.
  21. Oxford House Inc. (2011). Oxford House manual. Silver Springs, MD: Oxford House Inc.Google Scholar
  22. Schwartz, R. P., Kelly, S. M., O’Grady, K. E., Mitchell, S. G., Peterson, J. A., Reisinger, H. S., & Brown, B. S. (2008). Attitudes toward buprenorphine and methadone among opioid-dependent individuals. The American Journal on Addictions, 17, 396–401.  https://doi.org/10.1080/10550490802268835.CrossRefPubMedPubMedCentralGoogle Scholar
  23. Substance Abuse and Mental Health Services Administration. (2011). SAMHSA’s National Registry of Evidence-Based Programs and Practices. Rockville, MD: Author. Retrieved June 26, 2017, from http://www.nrepp.samhsa.gov/ViewIntervention.aspx.
  24. Walters, G. D. (1994). The drug lifestyle: One pattern or several? Psychology of Addictive Behaviors, 8, 8–13.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • John M. Majer
    • 1
  • Christopher Beasley
    • 2
    • 4
  • Emily Stecker
    • 2
  • Ted J. Bobak
    • 3
  • Joshua Norris
    • 3
  • Hai Minh Nguyen
    • 3
  • Maisie Ogata
    • 3
  • Jordana Siegel
    • 3
  • Brandon Isler
    • 3
  • Elzbieta Wiedbusch
    • 3
  • Leonard A. Jason
    • 3
  1. 1.Social Science DepartmentHarry S. Truman CollegeChicagoUSA
  2. 2.Psychology DepartmentWashington CollegeChestertownUSA
  3. 3.Center for Community ResearchDePaul UniversityChicagoUSA
  4. 4.Department of Social, Behavioral, and Human ServicesUniversity of WashingtonTacomaUSA

Personalised recommendations